A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
Solabegron
The risk or severity of hypertension can be increased when Solabegron is combined with Cannabidiol.
Potassium cation
Amibegron
The risk or severity of hypertension can be increased when Amibegron is combined with Cannabidiol.
Potassium cation
Cimicoxib
The risk or severity of hypertension can be increased when Cimicoxib is combined with Cannabidiol.
Potassium cation
Benoxaprofen
The risk or severity of hypertension can be increased when Benoxaprofen is combined with Cannabidiol.
Potassium cation
1-benzylimidazole
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Cannabidiol.
Potassium cation
Taxifolin
The risk or severity of hypertension can be increased when Taxifolin is combined with Cannabidiol.
Potassium cation
Epicaptopril
The risk or severity of hypertension can be increased when Epicaptopril is combined with Cannabidiol.
Potassium cation
Tiaprofenic acid
The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Cannabidiol.
Potassium cation
Phendimetrazine
The risk or severity of hypertension can be increased when Phendimetrazine is combined with Cannabidiol.
Potassium cation
Antrafenine
The risk or severity of hypertension can be increased when Antrafenine is combined with Cannabidiol.
Potassium cation
Bambuterol
The risk or severity of hypertension can be increased when Bambuterol is combined with Cannabidiol.
Potassium cation
Choline magnesium trisalicylate
The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Cannabidiol.
Potassium cation
Salsalate
The risk or severity of hypertension can be increased when Salsalate is combined with Cannabidiol.
Potassium cation
Magnesium salicylate
The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Cannabidiol.
Potassium cation
Ephedra sinica root
The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Cannabidiol.
Potassium cation
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.
Potassium cation
Sodium oxybate
Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Potassium cation
Rufinamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rufinamide.
Potassium cation
Rotigotine
Cannabidiol may increase the sedative activities of Rotigotine.
Potassium cation
Perampanel
Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Perampanel.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3